RENOVORX ADVANCES TAMP™ INTO BORDERLINE RESECTABLE PANCREATIC CANCER WITH FIRST PATIENT ENROLLED IN INVESTIGATOR-INITIATED PRISM-TAMP TRIAL

Reuters · 2d ago

Please log in to view news